多年多指标协议,以支持患者获得多个指标的瘤药物:一种实验性方法还是留在这里?
Hannah Armstrong1, Angelina Petrova1, Tim Wilsdon1
1Charles River Associates, London EC2M 7EA, UK.
多年多指标 (MYMI) 协议有助于癌症患者获得创新的治疗方法. 虽然在某些领域取得了成功,但MYMI协议需要适应医疗保健系统,以最大限度地提高患者的利益和管理成本.
科学领域:
- 卫生经济学 卫生经济学
- 在瘤学瘤学.
- 制药政策 制药政策
背景情况:
- 多种指示的瘤药物的兴起给定价和补偿带来了挑战.
- 传统系统在价值评估,患者获取时间表,负担能力和这些复杂疗法的预算影响方面扎.
研究的目的:
- 评估多年多指标 (MYMI) 协议的进展和有效性.
- 评估MYMI协议是否为患者,医疗保健系统和制药创新者提供预期的好处.
主要方法:
- 综述最近在不同国家实施MYMI的进展情况.
- 分析MYMI协议对患者获取,医疗保健系统效率和预算可预测性的影响.
主要成果:
- MYMI协议已经成功地解决了多种指示产品退款和患者获取的挑战.
- 对患者的好处,例如更快地获得新指示,在一些国家实现了,但并非所有国家.
- 某些系统的行政负担可能会破坏预期的效率增长.
结论:
- MYMI协议并不普遍适用,需要根据特定的医疗保健系统量身定制.
- 虽然MYMI可以提高支付人的预算可预测性,但其成功取决于适应当地环境,以确保最佳的患者结果和系统效率.
更多相关视频
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
相关概念视频
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Clinical Trials: Overview
